Primary central nervous system lymphoma epidemiology and demographics: Difference between revisions
No edit summary |
|||
| Line 8: | Line 8: | ||
==Age== | ==Age== | ||
Primary central nervous system lymphoma does not have predilections for any age group. | Primary central nervous system lymphoma does not have predilections for any age group. In the immunocompetent population, PCNSL typically affects older patients in their 50's and 60's. | ||
==References== | ==References== | ||
Revision as of 06:38, 17 September 2012
|
Primary central nervous system lymphoma Microchapters |
|
Differentiating Primary Central Nervous System Lymphoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Primary central nervous system lymphoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Primary central nervous system lymphoma epidemiology and demographics |
|
FDA on Primary central nervous system lymphoma epidemiology and demographics |
|
CDC on Primary central nervous system lymphoma epidemiology and demographics |
|
Primary central nervous system lymphoma epidemiology and demographics in the news |
|
Blogs on Primary central nervous system lymphoma epidemiology and demographics |
|
Directions to Hospitals Treating Primary central nervous system lymphoma |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.
Overview
Age
Primary central nervous system lymphoma does not have predilections for any age group. In the immunocompetent population, PCNSL typically affects older patients in their 50's and 60's.